India to Mexico: Cyclophosphamide Export Trade Route

The India to Mexico Cyclophosphamide corridor is one of India's established pharmaceutical export routes, with 81 shipments documented worth a combined $256.5K USD. The route is dominated by GLS PHARMA LIMITED, which alone accounts for roughly 42% of all export value, reflecting the consolidated nature of India's cyclophosphamide manufacturing sector.

Across 14 active suppliers, the average shipment value stands at $3.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with cyclophosphamide's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 31.7%, placing it at rank #15 among India's top cyclophosphamide export destinations globally.

On the import side, key buyers of Indian cyclophosphamide in Mexico include CALLEX MEDICAMENTOS S. DE RL DE CV, ACCORD FARMA S A DE C V, TO THE ORDER OF""" and 16 others. CALLEX MEDICAMENTOS S. DE RL DE CV is the single largest importer with 19 shipments valued at $88.1K USD.

India's cyclophosphamide exports to Mexico are driven primarily by a handful of large-scale manufacturers. GLS PHARMA LIMITED with 23 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market — buyers in Mexico benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GLS PHARMA LIMITED, INTAS PHARMACEUTICALS LTD, GENETEC LIFESCIENCES — together account for 78% of total trade value on this route. The average shipment value of $3.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ponfecyc 200mg injection (cyclophosphamide for injection 200mg/vial)vls and ponfecyc 500mg injection (cyclophosphamide for injection 500mg/vial)vls, suggesting that buyers in Mexico tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CALLEX MEDICAMENTOS S. DE RL DE CV is the largest importer with 19 shipments worth $88.1K USD — representing 34% of all cyclophosphamide imports from India on this route. A total of 19 buyers are active on this corridor.